Sep 30, 2025
AbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with Limited Treatment Options
Sep 29, 2025
AbbVie Breaks Ground on New North Chicago Active Pharmaceutical Ingredient Manufacturing Facility
Sep 23, 2025
Allergan Aesthetics Announces Expansion of SKINVIVE by JUVÉDERM® into 35 New Markets, Reinforcing its Commitment to Advancing Global Skin Quality
Sep 09, 2025
BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories
Sep 05, 2025
AbbVie Declares Quarterly Dividend
Sep 03, 2025
Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers
Sep 02, 2025
AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Aug 25, 2025
AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
Aug 21, 2025
AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata
Aug 19, 2025
SkinMedica® Unveils Its Newest Hydration Hero
Aug 19, 2025
AbbVie Completes Acquisition of Capstan Therapeutics
Aug 06, 2025
Get Ready, JUVÉDERM® Day is Calling!
Aug 05, 2025
Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency
Jul 31, 2025
AbbVie Reports Second-Quarter 2025 Financial Results
Jul 30, 2025
AbbVie Announces Positive Topline Results from Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata
Jul 29, 2025
AbbVie Submits for U.S. FDA Approval of Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
Jul 22, 2025
BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year's Entrepreneurs for The Confidence Project
Jun 30, 2025
AbbVie to Host Second-Quarter 2025 Earnings Conference Call
Jun 30, 2025
U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
Jun 30, 2025
AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology